IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury

Key Points

• IGFBP4 serves as a biomarker for assessing bile duct injury, potentially aiding diagnosis and treatment.
• The data indicates that higher IGFBP4 levels provide protective effects against biliary epithelial cell damage.
• Assessment through observational methods emphasizes the association of IGFBP4 with primary biliary cholangitis.
• Findings highlight the importance of IGFBP4 in clinical settings, advocating further investigations of its therapeutic potential.

Abstract